Primary peritoneal carcinoma (PPC) arises from the abdominal lining and behaves much like epithelial ovarian cancer. Diagnosis uses imaging, CA-125, and biopsy. Standard care remains cytoreductive surgery plus platinum-based chemotherapy; PARP inhibitors are now commonly used as maintenance in eligible patients. Long-term surveillance and genetic testing are important.
Primary peritoneal carcinoma is a rare, ovarian-type cancer of the abdominal lining. It causes vague symptoms such as bloating and abdominal pain and is treated like advanced ovarian cancer with surgery, platinum-based chemotherapy, and, when appropriate, targeted therapies including PARP inhibitors.
Modern ovarian cancer treatment combines surgery, platinum-based chemotherapy, and targeted maintenance therapies guided by tumor genetics and patient priorities. Multidisciplinary care, genetic testing, and clinical trials shape individualized plans.